Skip to main content
. 2018 Mar 7;41(6):zsy047. doi: 10.1093/sleep/zsy047

Table 1.

Baseline characteristics of participants from the Sleep Heart Health Study, 1995–1998 (n = 4994)

Characteristic No insomnia/poor sleep Insomnia or poor sleep Overall
n = 4994
P*
Normal sleep duration (n=2,489, 49.8%) Short sleep duration (n=1,801, 36.1%) Normal sleep duration
(n=350, 7.0%)
Short sleep duration
(n=354, 7.1%)
Age (years), mean ± SD 62.1 ± 11.1 66.3 ± 10.7 63.2 ± 11.0 66.1 ± 11.2 64.0 ± 11.1 <.0001
Race, n (%) .83
 White
2179 (87.5%) 1566 (87.9%) 301 (86.0%) 307 (86.7%) 4353 (87.2%)
 Black/other 310 (12.5%) 235 (13.1%) 49 (14.0%) 47 (13.3%) 641 (12.8%)
Female, n (%) 1,412 (56.7%) 789 (43.8%) 268 (76.6%) 205 (57.9%) 2,674 (53.5%) <.0001
Smoking status, n (%) <.001
 Current 217 (8.7%) 177 (9.8%) 38 (10.9%) 48 (13.6%) 480 (9.6%)
 Former 1,054 (42.4%) 851 (41.3%) 148 (42.3%) 153 (43.2%) 2206 (44.2%)
 Never 1218 (48.9%) 773 (42.9%) 164 (46.8%) 153 (43.2%) 2308 (46.2%)
Antidepressant usage, n (%) 140 (5.6%) 96 (5.3%) 82 (23.4%) 55 (15.5%) 373 (7.5%) <.0001
Weekday,self-reported sleep duration (hr/night), mean ± SD 7.3 ± 1.0 7.0 ± 1.2 6.4 ± 1.4 5.9 ± 1.5 7.1 ± 1.2 <.0001
Weekend, self-reported sleep duration (hr/night), mean ± SD 7.7 ± 1.1 7.4 ± 1.2 6.7 ± 1.6 6.2 ± 1.6 7.4 ± 1.3 <.0001
AHI (events/hr), median (IQR) 8.5 (3.5,17.2) 11.0 (5.2, 22.0) 7.6 (3.3,16.0) 9.8 (4.2,19.0) 9.4 (4.0,19.1) <.0001
BMI (kg/m2), median (IQR) 27.4 (24.7,30.6) 28.0 (24.9,31.2) 27.6 (24.9,30.9) 28.0 (24.8,31.4) 27.6 (24.8,30.9) <.01
Hypertension, n (%) 860 (34.6%) 833 (46.3%) 137 (39.1%) 186 (52.5%) 2,016 (40.4%) <.0001
Baseline cardiovascular disease, n (%) 319 (12.8%) 313 (17.4%) 35 (10.0%) 69 (19.5%) 736 (14.7%) <.0001
Total cholesterol (mg/dL), mean ± SD 205 ± 37 205 ± 38 213 ± 38 212 ± 40 207 ± 38 .0001
HDL-C (mg/dL), mean ± SD 51.0 ± 15.3 49.5 ± 15.8 54.0 ± 17.1 50.3 ± 15.9 50.6 ± 15.7 <.0001
Diabetes, n (%) 158 (6.3%) 168 (9.3%) 18 (5.1%) 27 (7.6%) 371 (7.4%) <.01

AHI = apnea–hypopnea index; BMI = body mass index; HDL-C = high-density lipoprotein-cholesterol.

*Pearson’s chi-squared test for categorical characteristics; ANOVA for continuous characteristics.